GNAS and hepatocellular carcinoma: The objective of the current study is to detect the levels and changes of autoantibody to GNAS in patients at different stages during the formation of HCC combined with verification in serial sera from patients with chronic liver disease-transformed HCC to explore its diagnostic value for the early detection of HCC.